↓ Skip to main content

Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I

Overview of attention for article published in Stem Cell Research & Therapy, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
13 X users

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
59 Mendeley